133 related articles for article (PubMed ID: 10732964)
21. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
22. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
[TBL] [Abstract][Full Text] [Related]
24. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
Fu X; Tan PZ; Kula NS; Baldessarini R; Tamagnan G; Innis RB; Baldwin RM
J Med Chem; 2002 May; 45(11):2319-24. PubMed ID: 12014970
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
[TBL] [Abstract][Full Text] [Related]
27. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
Stenfors C; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):479-86. PubMed ID: 11692232
[TBL] [Abstract][Full Text] [Related]
28. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
[TBL] [Abstract][Full Text] [Related]
29. 3-(omega-Aminoalkyl)-5,5-dialkyl(or spirocycloalkyl-1',5-)hydantoins as new 5-HT1A and 5-HT2A receptor ligands.
Byrtus H; Pawłowski M; Charakchieva-Minol S; Duszyńska B; Mokrosz MJ; Mokrosz JL; Zejc A
Arch Pharm (Weinheim); 1996 Jun; 329(6):283-90. PubMed ID: 8767112
[TBL] [Abstract][Full Text] [Related]
30. New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.
Liégeois JF; Eyrolles L; Ellenbroek BA; Lejeune C; Carato P; Bruhwyler J; Géczy J; Damas J; Delarge J
J Med Chem; 2002 Nov; 45(23):5136-49. PubMed ID: 12408724
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
32. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
Homan EJ; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
[TBL] [Abstract][Full Text] [Related]
33. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
[TBL] [Abstract][Full Text] [Related]
35. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
38. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
Kossakowski J; Raszkiewicz A; Bugno R; Bojarski AJ
Pol J Pharmacol; 2004; 56(6):843-8. PubMed ID: 15662099
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues.
Bronowska A; Chilmonczyk Z; Leś A; Edvardsen O; Ostensen R; Sylte I
J Comput Aided Mol Des; 2001 Nov; 15(11):1005-23. PubMed ID: 11989622
[TBL] [Abstract][Full Text] [Related]
40. 1-Substituted-4-[3-(1,2,3,4-tetrahydro-5- or 7-methoxynaphthalen-1-yl)propyl]piperazines: influence of the N-1 piperazine substituent on 5-HT1A receptor affinity and selectivity versus D2 and alpha1 receptors. Part 6.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
Bioorg Med Chem; 2000 May; 8(5):873-81. PubMed ID: 10881999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]